Development of Assays for High-Throughput Screening for Use in Probe and Pre-therapeutic Discovery (R01)
The summary for the Development of Assays for High-Throughput Screening for Use in Probe and Pre-therapeutic Discovery (R01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Development of Assays for High-Throughput Screening for Use in Probe and Pre-therapeutic Discovery (R01): The participating NIH Institutes and Centers invite Research Project Grant (R01) applications to develop assays for high throughput screening (HTS) for use in Probe and Pre-therapeutic Discovery. Through this FOA, NIH wishes to stimulate research in 1) developing assays for specific biological targets and disease mechanisms relevant to the mission of participating NIH Institutes with the intent to screen for small molecule compounds that show potential as probes for use in advancing knowledge about the known targets, identifying new targets, or as pre-therapeutic leads; and 2) establishing collaboration with screening centers that have the requisite expertise and experience needed in implementation of HTS assays for the discovery and development of small molecule chemical probes. This FOA seeks to establish a stream of scientifically and technologically outstanding assays for screening by the NIH Molecular Libraries Production Centers Network (MLPCN) in the Molecular Libraries Program (MLP) and other academic centers. One important criterion for this initiative is novelty, so applicants are therefore encouraged to avoid focusing on areas and approaches that have been extensively targeted in other settings. Assays should be relevant to the scope of research in at least one of the participating NIH Institutes.
Federal Grant Title: | Development of Assays for High-Throughput Screening for Use in Probe and Pre-therapeutic Discovery (R01) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Education Food and Nutrition Health Income Security and Social Services |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-13-364 |
Type of Funding: | Grant |
CFDA Numbers: | 93.242, 93.273, 93.279, 93.393, 93.394, 93.395, 93.396, 93.399, 93.847, 93.855, 93.856, 93.859, 93.865, 93.866 |
CFDA Descriptions: | Mental Health Research Grants; Alcohol Research Programs; Drug Abuse and Addiction Research Programs; Cancer Cause and Prevention Research; Cancer Detection and Diagnosis Research; Cancer Treatment Research; Cancer Biology Research; Cancer Control; Diabetes, Digestive, and Kidney Diseases Extramural Research; Allergy, Immunology and Transplantation Research; Microbiology and Infectious Diseases Research; Biomedical Research and Research Training; Child Health and Human Development Extramural Research; Aging Research |
Current Application Deadline: | Jan 7, 2017 |
Original Application Deadline: | Jan 7, 2017 |
Posted Date: | Sep 27, 2013 |
Creation Date: | Sep 27, 2013 |
Archive Date: | Feb 7, 2017 |
Total Program Funding: | |
Maximum Federal Grant Award: | none |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Special district governments
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Independent school districts
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Native American tribal governments (Federally recognized)
Private institutions of higher education
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
County governments
Small businesses - Additional Information on Eligibility
- Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/pa-files/PAR-13-364.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • Lethal Means Safety Suicide Prevention Research in Healthcare and Community Settings (R34 ...
- • Strategies to Improve Health Outcomes and Advance Health Equity in Rural Populations (R01 ...
- • Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional)
- • Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...
- • Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...
- • Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)